Forest Laboratories Inc
Trending Articles
Related Content
Regulatory
Forest Laboratories UK applies for marketing authorisation for dry powder inhalation antibiotic
<p>Forest Laboratories UK (a subsidiary of global pharmaceutical company Forest Laboratories Inc) has applied to the European Medicines Evaluation Agency (EMEA) to license its new formulation dry powder colistimethate sodium for inhalation by cystic fibrosis patients. </p>